Security key
98422E103
Xeris Biopharma Holdings, Inc. - Common Stock (XERS)
CUSIP: 98422E103
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 40,971,724
- Total 13F value
- $120,062,000
- Share change
- +40,254,597
- Put/Call ratio
- 34%
- SEC-reported price per share
- $2.93
- Number of holders
- 85
- Value change
- +$117,961,261
- Number of buys
- 84
- Shares outstanding
- 165,974,436
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
85
Top holders
10
XERS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Xeris Biopharma Holdings, Inc. SEC filings
Xeris Biopharma Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98422E103
Recent filing periods:
Ownership snapshot
Top reported holders of XERS - Xeris Biopharma Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GEODE CAPITAL MANAGEMENT,...
Disclosed value leader
Sessa Capital IM, L.P.
Comparable rows
1/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 0.42%
14 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
GEODE CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 0.42%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GEODE CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 1
GEODE CAPITAL MANAGEMENT, LLC
0.42%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.42%
|
$1,725,000
704,170 shares
|
— | 30 Sep 2021 |
| Sessa Capital IM, L.P. |
13F
Company
|
—
class O/S missing
|
$8,970,000
3,661,237 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$7,292,000
2,976,180 shares
|
— | 30 Sep 2021 |
| Invesco Ltd. |
13F
Company
|
—
class O/S missing
|
$4,990,000
2,036,814 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$3,739,000
1,525,808 shares
|
— | 30 Sep 2021 |
| Redmile Group, LLC |
13F
Company
|
—
class O/S missing
|
$3,329,000
1,358,825 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
85
Shares
40,971,724
Rows available
85
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
1
Q4 2021 holders
85
Holder diff
84
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend